MedPath

Affiliated Hospital of Changchun University of Chinese Medicine

🇨🇳China
Ownership
Private
Established
1955-01-01
Employees
-
Market Cap
-
Website
http://www.jlhtcm.com

Clinical Trials

10

Active:0
Completed:0

Trial Phases

4 Phases

Early Phase 1:2
Phase 1:5
Phase 2:1
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials

Phase 1
5 (50.0%)
Early Phase 1
2 (20.0%)
Not Applicable
2 (20.0%)
Phase 2
1 (10.0%)

Effects of Yangxinshi Pills on the Exercise Tolerance of the Patients With Coronary Heart Disease

Phase 2
Conditions
Coronary Heart Disease
Interventions
Drug: Yangxinshi pill
Drug: conventional coronary heart disease medicine
Drug: Placebos
First Posted Date
2018-03-27
Last Posted Date
2018-03-27
Lead Sponsor
Affiliated Hospital of Changchun University of Chinese Medicine
Target Recruit Count
90
Registration Number
NCT03478332
Locations
🇨🇳

Changchun Traditional Medicine University Affiliated Hospital, Chang Chun, Ji Lin, China

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.